Zacks.com on MSN12h
Boston Scientific Expects Strong Gains in 2025: Time to Buy the Stock?Boston Scientific Corporation BSX, despite industrywide macroeconomic upheavals, has been seeing strong growth momentum ...
Blue Trust Inc. reduced its position in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 42.9% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The ...
1d
Allspring Global Investments Holdings LLC increased its stake in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 56 ...
Barchart on MSN3d
Do Wall Street Analysts Like Becton, Dickinson and Company Stock?Headquartered in Franklin Lakes, New Jersey, Becton, Dickinson and Company (BDX) is a global leader in medical technology ...
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Piper Sandler analyst Jason Bednar maintained a Buy rating on Becton Dickinson (BDX – Research Report) today and set a price target of $280.00.
Barclays analyst Matt Miksic maintained a Buy rating on Becton Dickinson (BDX – Research Report) today and set a price target of $278.00. The ...
Becton Dickinson plans to spin off its Biosciences and Diagnostic Solutions unit, targeting a fiscal 2026 completion, while updating FY25 revenue guidance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback